Table 3.

Drug resistance rate of five GNB to antibiotics in patients with COVID-19 from January to April in Isfahan, Iran.

Antibiotics	K. pneumoniae (47)			A. baumannii (35)			E. coli (1)			P. aeruginosa (1)			Enterobacter spp. (1)
	S%	I%	R%	S%	I%	R%	S%	I%	R%	S%	I%	R%	S%	I%	R%
Ceftazidime	2.1	0	97.9	0	0	100	100	0	0	0	0	100	100	0	0
Ceftriaxone	2.1	0	97.9	0	0	100	0	0	100	0	0	100	0	0	100
Cefepime	2.1	0	97.9	0	0	100	100	0	0	100	0	0	100	0	0
Ampicillin/sulbactam	2.1	0	97.9	34.3	5.7	60	0	0	100	0	0	100	0	0	100
Piperacillin/tazobactam	2.1	0	97.9	0	0	100	100	0	0	100	0	0	100	0	0
Meropenem	4.2	0	95.8	0	0	100	100	0	0	100	0	0	0	0	100
Amikacin	17	2.1	80.9	5.7	0	94.3	100	0	0	100	0	0	0	0	100
Gentamicin	6.4	0	93.6	2.8	0	97.2	100	0	0	100	0	0	0	0	100
Ciprofloxacin	2.1	0	97.9	0	0	100	0	0	100	0	0	100	0	0	100
Levofloxacin	4.2	0	95.8	0	0	100	0	0	100	0	0	100	0	0	100
Colistin	89.4	0	10.6	100	0	0	100	0	0	100	0	0	0	0	100